Fas Antigen (CD95) Expression in Peripheral Blood Progenitor Cells from Patients with Leukaemia and Lymphoma

References

• Koury M.J. Programmed cell death (apoptosis) in hematopoiesis. Experimental Hematology 1992; 20: 391–394
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Krammer P.H., Dhein J., Walczak H., Bermann I., Mariani S., Matiba B., Fath M., Daniel P.T., Knipping E., Westendrop M.O., Strieker K., Bäumler C., Hellbardt S., Germer M., Peter M.E., Debatin K-M. The role of APO-I-mediated apoptosis in the immune system. Immunological Reviews 1994; 142: 175–191
   PubMed Web of Science ®Google Scholar
• Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H., Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84: 1201–1208
   PubMed Web of Science ®Google Scholar
• Maciejewski J., Selleri C., Anderson S., Young N.S. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85: 3183–3190
   PubMed Web of Science ®Google Scholar
• Nishiuchi R., Yoshino T., Matsuo Y., Sakuma Y., Cao L., Seino Y., Takahashi K., Akagi T. The Fas antigen is detected on immature B-cells and the representative cell lines show Fas-mediated apoptosis. British Journal of Haematology 1996; 92: 302–307
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Manley T.J., Pichert G., Cameron C., Cochran K.J., Levine H., Ritz J. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leukemia and Lymphoma 1995; 17: 51–61
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Shibuya T., Harada M., Mizuno S., Takenaka K., Miyamoto T., Okamura T., Gondo H., Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86: 883–889
   PubMed Web of Science ®Google Scholar
• Nagafugi K., Takenaka K., Shibuya T., Harada M., Niho Y. Fas antigen (CD95) and hematopoietic progenitor cells. Leukemia and Lymphoma 1996; 24: 43–56
   PubMed Web of Science ®Google Scholar
• Takenaka K., Nagafugi K., Harada M., Mizuno S., Miyamoto T., Makino S., Gopndo H., Okamura T., Niho Y. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 1996; 88: 2871–2877
   PubMed Web of Science ®Google Scholar
• Selleri C., Sato T., del Vecchio L., Luciano L., Barrett A.J., Rotoli B., Young N.S., Maciejewski P. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon α in chronic myelogenous leukemia. Blood 1997; 89: 957–964
   PubMed Web of Science ®Google Scholar
• Yoshino T., Kondo E., Cao L., Takahashi K., Hayashi K., Nomura S., Akagi T. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B-lymphocytes. Blood 1994; 83: 1865–1861
   Web of Science ®Google Scholar
• Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., Yonehara S., Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopu-lations in human peripheral blood. Journal of Immunology 1992; 149: 3753–3758
   PubMed Web of Science ®Google Scholar
• Anderson K.C. Autologous peripheral blood progenitor cell transplantation. Journal of Clinical Apheresis 1995; 10: 131–138
   PubMed Web of Science ®Google Scholar
• Giannî A.M., Bergni M., Stern A.C., Siena S., Tarella C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; ii: 580–585
   Google Scholar
• Haas R., Hohaus S., Egerer G., Erhhardt R., Witt B., Hunstein W. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplantation 1992; 9: 459–465
   PubMed Web of Science ®Google Scholar
• Dreger P., Glass B., Uharek L., Schmitz N. Allogeneic peripheral blood progenitor cells: current status and future directions. Journal of Hematotherapy 1996; 5: 331–337
   PubMedGoogle Scholar
• Sienna S., Bregni M., Di Nicola M., Ravagnani F., Peccatori F., Gandola L., Lombardi F., Tarella C., Bonadonna G., Giannî A.M. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Annals of Oncology 1994; 5: 935–941
   PubMed Web of Science ®Google Scholar
• Stahnke K., Hecker S., Kohne E., Debatin K-M. CD95 (APO-I/FAS) mediated apoptosis in cytokine activated hematopoietic cells. Blood 1996; 88: S1, 343a
   PubMed Web of Science ®Google Scholar
• Min Y.H., Lee S., Lee J.W., Chong S.Y., Hahn J.S., Ko Y.W. Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy. British Journal of Haematology 1996; 93: 928–930
   PubMed Web of Science ®Google Scholar
• Karawajew L., Wuchter C., Ruppert V., Dörken B., Ludwig W.D. Differential susceptibility to CD95-induced apoptosis in acute myeloid leukemia (AML): dependence on CD34—phenotype and growth characteristics in vitro. Blood 1996; 88(SI)2240
   Google Scholar
• Craig J.I.O., Langlands K., Parker A.C., Anthony R.S. Molecular detection of tumor contamination in peripheral blood stem cell harvests. Experimental Hematology 1994; 22: 898–902
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Savolodo B., Regazzi E., Garau D., Sammarelli G., Mangoni L., Almici C., Frassoni F., Rizzoli V. Chronic myelogenous leukemiaCD34+ marrow cells lacking CD95 expression are enriched for bcr/abl negative primitive and committed progenitors. Blood 1996; 88: S1, 574a
   PubMed Web of Science ®Google Scholar
• Shima Y., Nishimoto N., Ogata A., Fujii Y., Yoshizaki K., Kishimoto T. Myeloma cells express Fas anti-gen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood 1995; 85: 757–764
   PubMed Web of Science ®Google Scholar
• Dirks W., Schone S., Uphoff C., Quentmeier H., Pradella S., Drexler H.G. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. British Journal of Haematology 1997; 96: 584–593
   PubMed Web of Science ®Google Scholar
• Debatin K.M., Krammer P.H. Resistance to Apo-1 (CD95)-induced apoptosis in T-ALL is determined by a bcl-2 independent anti-apoptotic program. Leukemia 1995; 9: 812–815
   Web of Science ®Google Scholar
• Kvalheim G., Manara M.Y., Høifødt H., Yu W.M., Smeland E., Bargou R., Krammer P., Dörken B. Triggering of the APO-1/Fas antigen (CD95) selectively kills leukemic cells without compromising hematopoietic stem cells: a novel strategy for tumor cell purging of autografts. Blood 1994; 84(S1)570a
   PubMed Web of Science ®Google Scholar
• Kotani T., Aratake Y., Kondo S., Tamura K., Ohtaki S. Expression of functional Fas antigen in adult T-cell leukemia. Leukemia Research 1994; 18: 305–310
   PubMed Web of Science ®Google Scholar
• Debatin K.-M., Goldman C.K., Waldmann T.A., Krammer P.H. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81: 2972–2977
   PubMed Web of Science ®Google Scholar
• Munker R., Lubbert M., Yonehara S., Tuchnitz A., Mertelsmann R., Wilmanns W. Expression of the Fas antigen on primary human leukemia cells. Annals of Hematology 1995; 70: 15–17
   PubMed Web of Science ®Google Scholar
• Talmadge J.E., Singh R.K., Ageitos A., Ozerol I., Ino K. T-cell apoptosis (mediated in part by Fas ligand) by monocytes in cytokine mobilized stem cell products; resultant immunosuppression. Blood 1996; 88(S1)610a
   Google Scholar
• Sica S., Rutella S., Di Mario A., Salutari P., Rumi C., Ortu la Barbera E., Etuk B., Menichella G., D'Onofrio G., Leone G. rhG-CSF in healthy donors: mobilization of peripheral hematopoietic progenitors and effect on peripheral blood leukocytes. Journal of Hematotherapy 1996; 5: 391–397
   PubMedGoogle Scholar
• Körbling M., Huh Y.O., Durett A., Mirza N., Miller P., Engel H., Anderlini P., Vanbesien K., Andreef M., Przepiorka D., Deisserofh A.B., Champlin R.E. Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842–2848
   PubMed Web of Science ®Google Scholar
• Besinger W.I., Weaver C.H., Appelbaum F.R., Rowley S., Demirer T., Sanders J., Storb R., Buckner C.D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655–1658
   PubMed Web of Science ®Google Scholar